Swiss Pharmaceuticals & Biotech Profitable Climbers

Newron Pharmaceuticals

Market Cap: CHF 542.4m

A biopharmaceutical company, discovers and develops novel therapies for patients with diseases of the central and peripheral nervous system in Italy and the United States.

Cosmo Pharmaceuticals

Market Cap: CHF 1.7b

Focuses on the development and commercialization products for gastroenterology, dermatology, and healthtech worldwide.

Sandoz Group

Market Cap: CHF 26.1b

Develops, manufactures, and markets generic pharmaceuticals and biosimilars worldwide.

SKAN Group

Market Cap: CHF 1.2b

Provides isolators, cleanroom devices, and decontamination processes for pharmaceutical and chemical industries in Europe, the Americas, Asia, and internationally.

Galderma Group

Market Cap: CHF 39.2b

Operates as a dermatology company worldwide.